Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of MXN 5.11 trillion. The enterprise value is 5.60 trillion.

Market Cap	5.11T
Enterprise Value	5.60T

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.25%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.53B

Valuation Ratios

The trailing PE ratio is 21.49.

PE Ratio	21.49
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	45.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.70, with an EV/FCF ratio of 19.26.

EV / Earnings	23.53
EV / Sales	4.31
EV / EBITDA	11.70
EV / EBIT	14.41
EV / FCF	19.26

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.86.

Current Ratio	1.36
Quick Ratio	0.92
Debt / Equity	0.86
Debt / EBITDA	1.64
Debt / FCF	2.57
Interest Coverage	15.08

Financial Efficiency

Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 14.87%.

Return on Equity (ROE)	28.33%
Return on Assets (ROA)	10.53%
Return on Invested Capital (ROIC)	14.87%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	17.42M
Profits Per Employee	3.35M
Employee Count	72,000
Asset Turnover	0.56
Inventory Turnover	2.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.90% in the last 52 weeks. The beta is 0.41, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-2.90%
50-Day Moving Average	2,036.39
200-Day Moving Average	2,170.16
Relative Strength Index (RSI)	50.06
Average Volume (20 Days)	996

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.91

Income Statement

In the last 12 months, Merck & Co. had revenue of MXN 1.24 trillion and earned 237.89 billion in profits. Earnings per share was 93.60.

Revenue	1.24T
Gross Profit	947.57B
Operating Income	370.00B
Pretax Income	268.67B
Net Income	237.89B
EBITDA	448.99B
EBIT	370.00B
Earnings Per Share (EPS)	93.60

Full Income Statement

Balance Sheet

The company has 285.77 billion in cash and 746.71 billion in debt, giving a net cash position of -460.94 billion.

Cash & Cash Equivalents	285.77B
Total Debt	746.71B
Net Cash	-460.94B
Net Cash Per Share	n/a
Equity (Book Value)	872.61B
Book Value Per Share	344.18
Working Capital	211.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 357.66 billion and capital expenditures -67.05 billion, giving a free cash flow of 290.61 billion.

Operating Cash Flow	357.66B
Capital Expenditures	-67.05B
Free Cash Flow	290.61B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.59%, with operating and profit margins of 29.91% and 19.23%.

Gross Margin	76.59%
Operating Margin	29.91%
Pretax Margin	21.72%
Profit Margin	19.23%
EBITDA Margin	36.29%
EBIT Margin	29.91%
FCF Margin	23.49%

Dividends & Yields

This stock pays an annual dividend of 58.24, which amounts to a dividend yield of 2.90%.

Dividend Per Share	58.24
Dividend Yield	2.90%
Dividend Growth (YoY)	11.42%
Years of Dividend Growth	1
Payout Ratio	63.72%
Buyback Yield	0.25%
Shareholder Yield	3.15%
Earnings Yield	4.65%
FCF Yield	5.69%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.38.

Altman Z-Score	4.38
Piotroski F-Score	n/a